A Phase I, Prospective, Randomized, Open-Labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults
SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4214528  issn: 1556-5068 

Chia En Lien, Ming-Che Liu, Ning-Chi Wang, Luke Tzu Chi Liu, Chung-Chin Wu, Wei-Hsuan Tang, Wei-Cheng Lian, Kuan-Ying A. Huang, Charles Chen